Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 9Phase 1/2 4Phase 4 3Phase 3 3Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 437Recruiting 170Unknown 162Active not recruiting 135Terminated 125Not yet recruiting 53Withdrawn 23Suspended 3Enrolling by invitation 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 7Gastrointestinal 4Thoracic 3Other hematologic neoplasm 3Gynecologic 3Lymphoid 2Genitourinary 2Classical hematology 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other 1Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2NSCLC 1

Interventions

Surgical Procedures, Operative 1HM781-36B 1Docetaxel 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Suspended × Thoracic × Clear all
NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended
268 enrolled
Thoracic

NSCLC

NCT00540280 2011-03-08

Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

King Faisal Specialist Hospital & Research Center

Phase 3 Suspended
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00211952 2005-09-21

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

Medical University of Gdansk

Phase 3 Suspended
542 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡